drugset / Trial / NCT00329485

The Effect of Ribose on B-Type Natriuretic Peptide (BNP) Levels in Congestive Heart Failure Patients

NCT00329485

Terminated 120 enrolled Valen Labs
Non-randomizedSingle-groupOpen-label

Summary

The purpose of this research study is to test the effectiveness of CORvalen, a medical food, to increase cellular energy sufficiently to change or modify BNP levels in congestive heart failure patients.

Timeline

Start
2006-06
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject RIBOSE (PYRANOSE) Small molecule